Cytosorbents
CTSO
#9831
Rank
A$60.87 M
Marketcap
A$0.97
Share price
1.69%
Change (1 day)
-43.64%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -A$20.21 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$36.97 Million. In 2024 the company made an earning of -A$31.93 Million, an increase over its 2023 earnings that were of -A$41.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$20.21 Million-36.71%
2024 -A$31.93 Million-22.49%
2023 -A$41.2 Million-13.52%
2022 -A$47.63 Million34.04%
2021 -A$35.54 Million182.17%
2020 -A$12.6 Million-55.97%
2019 -A$28.6 Million14.17%
2018 -A$25.05 Million95.14%
2017 -A$12.84 Million-22.32%
2016 -A$16.53 Million39.1%
2015 -A$11.88 Million-12.89%
2014 -A$13.64 Million89%
2013 -A$7.22 Million26.65%
2012 -A$5.7 Million-26.02%
2011 -A$7.71 Million-288.45%
2010 A$4.08 M-4.17%
2009 A$4.26 M-287.19%
2008 -A$2.28 Million-47.12%
2007 -A$4.31 Million41.78%
2006 -A$3.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$4.59 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.09 B-6,233.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
A$77.97 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA